News Focus
News Focus
icon url

learningcurve2020

01/22/25 11:15 AM

#744847 RE: learningcurve2020 #744833

🤷🏼‍♀️
icon url

iclight

01/22/25 1:24 PM

#744879 RE: learningcurve2020 #744833

She was probably told that if Susan Bayh, who was on the board of directors of NWBO AND was diagnosed with glioblastoma, opted for immunotherapy treatment at Duke and not dendritic cell treatment at UCLA, she shouldn't bother as those actions speak for themselves.
icon url

scotty3371

01/22/25 2:33 PM

#744888 RE: learningcurve2020 #744833

They probably told the poor lady Adam Feuerstein said it dosen't work so take more chemotherapy.
Bullish
Bullish
icon url

XMaster2023

01/22/25 3:44 PM

#744904 RE: learningcurve2020 #744833

Doctors recommend SOC unless the patient pushes them in another direction. If a doctor recommends something other than the SOC that put them in legal jeopardy. Now let’s talk about a prominent person. This puts the doctor more at risk for malpractice. After MHRA approval things will change slightly. The doctor can say, “this treatment is approved in the UK” they could also export the tumor off to the UK to create the vaccine. This assumes the patient has 200K to pay for the vaccine. Even if you have to go to the UK to get the vaccine, it’s an option. For many patients, the 200k is not an issue.
Bullish
Bullish
icon url

Margin Buu

01/22/25 7:09 PM

#744916 RE: learningcurve2020 #744833

Why would she have "likely inquired"?